Association between HLA-B*46 allele and Graves disease in Asian populations: A meta-analysis

International Journal of Medical Sciences

Volumn 10, Issue 2, 2013, Pages 164-170

  Li, Yiping ^a,b   Yao, Yufeng ^c   Yang, Man ^b   Shi, Li ^c   Li, Xianli ^b   Yang, Ying ^b   Zhang, Ying ^b   Xiao, Chunjie ^a  

^a YUNNAN UNIVERSITY   (China)

^b Second People's Hospital of Yunnan Province   (China)

^c INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

Asian populations; Graves' disease; HLA B*46; Meta analysis

Indexed keywords

ARTICLE; ASIAN; CASE CONTROL STUDY; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GRAVES DISEASE; HLA B46 GENE; HUMAN;

ASIAN POPULATIONS.; GRAVES' DISEASE; HLA-B*46; META-ANALYSIS;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GRAVES DISEASE; HLA-B ANTIGENS; HUMANS; RISK FACTORS;

EID: 84872141874     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5158     Document Type: Article

References (52)

1. Weetman AP. Graves' disease. N Engl J Med. 2000;343:1236-48.
2. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84:223-43.
3. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7:481-93.
4. Shapira Y, Agmon-Levin N, Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun. 2010;34:J168-77.
5. Stenszky V, Kozma L, Balazs C, Rochlitz S, Bear JC, Farid NR. The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab. 1985;61:735-40.
6. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003;24:802-35.
7. Yanagawa T, Mangklabruks A, Chang YB, et al. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab. 1993;76:1569-74.
8. Yanagawa T, Mangklabruks A, DeGroot LJ. Strong association between HLA-DQA1*0501 and Graves' disease in a male Caucasian population. J Clin Endocrinol Metab. 1994;79:227-9.
9. Uno H, Sasazuki T, Tamai H, Matsumoto H. Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature. 1981;292:768-70.
10. Barlow AB, Wheatcroft N, Watson P, Weetman AP. Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women. Clin Endocrinol (Oxf). 1996;44:73-7.
11. Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ. Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet. 2000;95:432-7.
12. Hawkins BR, Ma JT, Lam KS, Wang CC, Yeung RT. Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese. Clin Endocrinol (Oxf). 1985;23:245-52.
13. Naito S, Sasaki H, Arakawa K. Japanese Graves' disease: association with HLA-Bw46. Endocrinol Jpn. 1987;34:685-8.
14. Yeo PP, Chan SH, Thai AC, et al. HLA Bw46 and DR9 associations in Graves' disease of Chinese patients are age- and sex-related. Tissue Antigens. 1989;34:179-84.
15. Inoue D, Sato K, Enomoto T, et al. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations. Clin Endocrinol (Oxf). 1992;36:75-82.
16. Inoue D, Sato K, Maeda M, et al. Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy. Clin Endocrinol (Oxf). 1991;34:57-62.
17. Dong RP, Kimura A, Okubo R, et al. HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum Immunol. 1992;35:165-72.
18. Chan SH, Lin YN, Wee GB, Ren EC, Lui KF, Cheah JS. Human leucocyte antigen DNA typing in Singaporean Chinese patients with Graves' disease. Ann Acad Med Singapore. 1993;22:576-9.
19. Onuma H, Ota M, Sugenoya A, Inoko H. Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese. Hum Immunol. 1994;39:195-201.
20. Cavan DA, Penny MA, Jacobs KH, et al. The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects. Clin Endocrinol (Oxf). 1994;40:63-6.
21. Ohtsuka K, Nakamura Y. Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients. Am J Ophthalmol. 1998;126:805-10.
22. Huang SM, Wu TJ, Lee TD, Yang EK, Shaw CK, Yeh CC. The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people. Tissue Antigens. 2003;61:154-8.
23. Chen PL, Fann CS, Chu CC, et al. Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles. PLoS One. 2011;6:e16635.
24. Cho WK, Jung MH, Choi EJ, Choi HB, Kim TG, Suh BK. Association of HLA alleles with autoimmune thyroid disease in Korean children. Horm Res Paediatr. 2011;76:328-34.
25. Tan S-H, Chan S-H, Lee B-W, Wee G-B, Wong H-B. HLA association in Singapore children with Grave's disease. Metabolism. 1988;37:518-9.
26. Tamai H, Tanaka K, Komaki G, et al. HLA and thyrotoxic periodic paralysis in Japanese patients. J Clin Endocrinol Metab. 1987;64:1075-8.
27. Chan SH, Yeo PP, Lui KF, et al. HLA and thyrotoxicosis (Graves' disease) in Chinese. Tissue Antigens. 1978;12:109-14.
28. Lee YJ, Huang CY, Ting WH, et al. Association of an IL-4 gene haplotype with Graves disease in children: experimental study and meta-analysis. Hum Immunol. 2011;72:256-61.
29. Greenacre MJ, Degos L. Correspondence analysis of HLA gene frequency data from 124 population samples. Am J Hum Genet. 1977;29:60-75.
30. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820-6.
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
32. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295:676-80.
33. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
34. Yeo PP, Chan SH, Lui KF, Wee GB, Lim P, Cheah JS. HLA and thyrotoxic periodic paralysis. Br Med J. 1978;2:930.
35. Singer DS, Mozes E, Kirshner S, Kohn LD. Role of MHC class I molecules in autoimmune disease. Crit Rev Immunol. 1997;17:463-8.
36. Farid NR, Stone E, Johnson G. Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol (Oxf). 1980;13:535-44.
37. Abecasis GR, Noguchi E, Heinzmann A, et al. Extent and distribution of linkage disequilibrium in three genomic regions. Am J Hum Genet. 2001;68:191-7.
38. Reich DE, Cargill M, Bolk S, et al. Linkage disequilibrium in the human genome. Nature. 2001;411:199-204.
39. Stephens JC, Schneider JA, Tanguay DA, et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science. 2001;293:489-93.
40. Bodmer WF. Evolutionary significance of the HL-A system. Nature. 1972;237:139-45.
41. Carrington M, Stephens JC, Klitz W, Begovich AB, Erlich HA, Mann D. Major histocompatibility complex class II haplotypes and linkage disequilibrium values observed in the CEPH families. Hum Immunol. 1994;41:234-40.
42. Djilali-Saiah I, Benini V, Daniel S, Assan R, Bach JF, Caillat-Zucman S. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens. 1996;48:87-92.
43. Sanchez-Mazas A, Djoulah S, Busson M, et al. A linkage disequilibrium map of the MHC region based on the analysis of 14 loci haplotypes in 50 French families. Eur J Hum Genet. 2000;8:33-41.
44. Dawkins R, Leelayuwat C, Gaudieri S, et al. Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev. 1999;167:275-304.
45. Ahmad T, Neville M, Marshall SE, et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet. 2003;12:647-56.
46. Ban Y, Davies TF, Greenberg DA, et al. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun. 2004;5:203-8.
47. Kupatawintu P, Pheancharoen S, Srisuddee A, Tanaka H, Tadokoro K, Nathalang O. HLA-A, -B, -DR haplotype frequencies in the Thai Stem Cell Donor Registry. Tissue Antigens. 2010;75:730-6.
48. Saito S, Ota S, Yamada E, Inoko H, Ota M. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens. 2000;56:522-9.
49. Tokunaga K, Ishikawa Y, Ogawa A, et al. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics. 1997;46:199-205.
50. Katsuren E, Awata T, Matsumoto C, Yamamoto K. HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ. Endocr J. 1994;41:599-603.
51. Tandon N, Mehra NK, Taneja V, Vaidya MC, Kochupillai N. HLA antigens in Asian Indian patients with Graves' disease. Clin Endocrinol (Oxf). 1990;33:21-6.
52. Tong ZH, Zhu G, Yan LX, Zhu J, Feng YG, Xu G. Association of HLA with Graves' disease in Chinese. Chin Med J (Engl). 1987;100:296-8.